Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

Investigating America’s Drug Shortage Crisis,” a series exploring the causes and possible solutions of a problem plaguing ...

The national shortage was caused by damage to a manufacturing plant in North Cove, North Carolina, that flooded due to Hurricane Helene, which hit the area in late September. The Baxter plant in North ...

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes ...

compounded drugs sold by 503B pharmacies “may not be identical or nearly identical to an FDA-approved drug unless the ...

But last week, when the FDA removed Lilly’s tirzepatide from its drug shortage list, it erased the compounders’ qualification to manufacture one of their two new cash cows. In response ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

Health experts offer these tips: check the national drug shortage list for your medication and possible alternatives. Don’t wait until your prescription is almost gone to refill it. Check other ...

The supply shortage began with a series of administrative actions against generic drug companies in 2021. More than 10 companies, including industry giants, were found to have committed quality ...